NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 152.19% | -545.80% | 141.01% | -198.92% | 83.99% |
| Total Depreciation and Amortization | 14.50% | -0.30% | 1.84% | 0.00% | 8.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -178.28% | 298.85% | -229.38% | 869.35% | -105.02% |
| Change in Net Operating Assets | 133.17% | -262.17% | 1,239.02% | -94.59% | 60.55% |
| Cash from Operations | 59.73% | -78.51% | 35.07% | -48.71% | 41.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -225.00% | 5.88% | -13.33% | -- | -- |
| Cash from Investing | -225.00% | 5.88% | -13.33% | -142.86% | 294.44% |
| Total Debt Issued | -61.09% | 77.13% | -66.93% | 462.55% | 2,356.67% |
| Total Debt Repaid | -13.12% | 58.46% | -- | -- | -- |
| Issuance of Common Stock | -43.50% | 790.54% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -103.99% | 227.94% | -188.16% | 261.96% |
| Cash from Financing | -62.02% | 82.38% | -36.95% | 51.21% | 322.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10,200.00% | 97.83% | -304.44% | 462.50% | 100.09% |